A Study to Learn About the Responses to the Combined COVID-19 and Flu Vaccine in Healthy People
A Phase 3, Randomized, Observer-Blinded Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza in Healthy Individuals
Category & Conditions: Respiratory Disease
Medicine: Combination COVID-19 and Influenza modRNA Vaccine (PF-07926307)
ClinicalTrials.gov Identifier (NCT): NCT06178991
Protocol ID: C5261002
Open Plain Language Summary Result:
Click here